Skip to main content
Download PDF

Effects of macrophages on the proliferation and cardiac differentiation of human induced pluripotent stem cells

Cell Communication and Signaling volume 20, Article number: 108 (2022) Cite this article

Abstract

Background

Macrophage phenotypes switch from proinflammatory (M1) to anti-inflammatory (M2) following myocardial injury. Implanted stem cells (e.g., induced pluripotent stem cells (iPSCs)) for cardiomyogenesis will inevitably contact the inflammatory environment at the myocardial infarction site. To understand how the macrophages affect the behavior of iPSCs, therefore, improve the therapeutic efficacy, we generated three macrophage subtypes and assessed their effects on the proliferation, cardiac differentiation, and maturation of iPSCs.

Methods

M0, M1, and M2 macrophages were polarized using cytokines, and their properties were confirmed by the expression of specific markers using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and immunofluorescence. The effects of macrophages on iPSCs were studied using Transwell co-culture models. The proliferative ability of iPSCs was investigated by cell counting and CCK-8 assays. The cardiac differentiation ability of iPSCs was determined by the cardiomyocyte (CM) yield. The maturation of CM was analyzed by the expression of cardiac-specific genes using RT-qPCR, the sarcomere organization using immunofluorescence, and the mitochondrial function using oxidative respiration analysis.

Results

The data showed that the co-culture of iPSCs with M0, M1, or M2 macrophages significantly decreased iPSCs’ proliferative ability. M2 macrophages did not affect the CM yield during the cardiac differentiation of iPSCs. Still, they promoted the maturation of CM by improving sarcomeric structures, increasing contractile- and ion transport-associated gene expression, and enhancing mitochondrial respiration. M0 macrophages did not significantly affect the cardiomyogenesis ability of iPSCs during co-culture. In contrast, co-culture with M1 macrophages significantly reduced the cardiac differentiation and maturation of iPSCs.

Conclusions

M1- or M2-polarized macrophages play critical roles in the proliferation, cardiac differentiation, and maturation of iPSCs, providing knowledge to improve the outcomes of stem cell regeneration therapy.

Video abstract

Introduction

Myocardial infarction (MI) remains the primary cause of mortality in patients with cardiovascular diseases worldwide [1, 2]. The massive loss of cardiomyocytes (CMs) during MI results in irreversible damage to the heart, eventually leading to heart failure [3]. One strategy to overcome the decreased cardiac performance post-MI is to replace dead tissue with functional CMs. Human induced pluripotent stem cell (iPSC)-derived CMs (iPSC-CMs) represent many aspects of human CMs, such as cardiac gene expression signatures, contractile function, electrophysiological properties, and metabolic characteristics, and have become a useful tool in cardiovascular studies, as well as a cell source for heart regeneration [4,5,6]. Many studies support the potential therapeutic benefits of iPSCs implanted in the injured myocardium, such as reducing the cardiac scar size and improving cardiac functions [7,8,9,10].

Macrophages are a key cell type involved in the inflammatory process post-MI [11, 12]. It is well recognized that following MI, the heart experiences monocyte invasion in the MI microenvironment [13]. M0 macrophages differentiated from monocytes are mature macrophages with a larger and more flattened morphology than monocytes. A switch from the M1 to M2 subtype is occurred during the healing process, suggesting the differential contribution of these macrophage subtypes to the post-MI microenvironment [14,15,16,17,18]. M1 macrophages involved in 1–3 days post-MI display a proinflammatory phenotype with increased proinflammatory cytokine secretion. In contrast, M2 macrophages secrete high levels of anti-inflammatory cytokines and promote angiogenesis and tissue remodeling on days 5–7 post-MI.

Once transplanted, iPSCs are surrounded by the inflammatory environment post-MI, which consists of inflammatory cells such as M1 and M2 macrophages. However, little is known about the effects of different macrophage subtypes on iPSC behavior. Here, we addressed these issues by studying the effect of exposing M0, M1, and M2 macrophages to iPSCs, in terms of proliferation, cardiac differentiation, and maturation, using co-culture models.

Materials and methods

Polarization of macrophages

THP-1 cells were cultured and polarized according to established protocols [19]. Briefly, THP-1 cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS). An amount of 1 × 106 cells was plated in 6-well plates with 2 ml of medium containing 25 ng/ml PMA (catalog number: P8139; Sigma-Aldrich) for 2 days to acquire adherent cells (M0 macrophages). M0 macrophages were then treated for another 2 days with 20 ng/ml IFN-γ (PeproTech, catalog number: 300-02) and 100 ng/ml LPS (Sigma-Aldrich, catalog number: L2630) or with 20 ng/ml IL-4 (PeproTech, catalog number: 200–04) and 20 ng/ml IL-13 (PeproTech, catalog number: 200-13) to yield M1 or M2 polarized macrophages, respectively.

Co-culture transwell system

In total, 8 × 104 macrophages were seeded in a 0.4 μm pore insert of 24-well Transwell plates with 200 μl of PSCeasyII culture medium (Cellapy, catalog number: CA1014500) or differentiation medium (Cellapy, catalog number: CA2004500). Approximately 5 × 104 iPSCs were cultured on Matrigel-coated (Cellapy, catalog number: CA3003100) wells with 800 μl of PSCeasyII culture medium for the proliferation study. After 6 days of cardiac differentiation, the cardiac mesoderm precursors were co-cultured with macrophages in the differentiation medium for cardiac maturation studies.

Cell viability of iPSCs

After adding 10 μl of CCK8 solution (Beyotime, catalog number: C0038), the cells were incubated at 37 °C for 1 h. Optical density (OD) at 450 nm was recorded using a microplate reader (BioTek).

Human iPSC culture

Human iPSCs derived from urine renal epithelial cells of a 37-year-old man were purchased from Cellapy Biological Technology Company (Beijing, China, catalog number: CA1002008). Human iPSCs were cultured as previously described [20, 21]. Briefly, iPSCs were cultured on Matrigel-coated plates with PSCeasyII culture medium (modified Essential 8 medium) at 37 °C in a humidified atmosphere of 5% CO2. The medium was refreshed every day, and the cells were routinely split 1:10, after reaching 70–80% confluence, onto pre-coated plates using dissociation medium (Cellapy, catalog number: CA3001500).

Differentiation of iPSCs into CMs

Cardiac differentiation of iPSCs was performed using the CardioEasy Human Cardiomyocyte Differentiation Kit (Cellapy, catalog number: CA2004500). Briefly, cells were seeded at a confluence of 80–90% before differentiation. Then, the cardiac mesoderm precursors were induced using medium I for 2 days, subsequently changing to medium II for another 2 days. The medium was then changed to medium III and refreshed every 2 days. Contracting cells were observed at approximately day 8. On day 12, purification medium (Cellapy, catalog number: CA2005100) was used to metabolically select and purify CMs.

Bright-field images

Bright-field images were captured using a Mshot MF53-N microscope with a 10 × PhL contrast filter lens.

Immunofluorescence analysis

Immunostaining of cultured cells was carried out as previously described [22] using primary antibodies at a dilution of 1:200 in PBS containing 5% bovine serum albumin (Sigma-Aldrich, catalog number: A1933) as follows: rabbit anti-CCR7 (Beyotime, catalog number: AF1102), rabbit anti-CD36 (Beyotime, catalog number: AF6414), and rabbit anti-α-actinin (Proteintech, catalog number: 14221–1-AP). The secondary antibodies used were Alexa 488-conjugated goat anti-rabbit IgG (H + L) (Thermo Fisher Scientific, catalog number: A32731) and Alexa 568-coupled goat anti-rabbit IgG (H + L) (Thermo Fisher Scientific, catalog number: A11010). The secondary antibodies were diluted 1:400 in PBS. Nuclei were visualized using Hoechst 33,342 (10 µg/µl; Thermo Fisher Scientific, catalog number: H3570). Stained cells were imaged using a Zeiss LSM 900 confocal laser scanning microscope.

Total RNA extraction and reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

RT-qPCR was performed as previously described [23]. Total RNA was isolated using TRIzol reagent (Invitrogen, catalog number: 15596026), according to the manufacturer's protocol. RNA was reverse transcribed using the PrimeScript RT reagent kit (Takara, catalog number: RR037A). The expression levels of the genes of interest were determined by PCR using TB Green Premix Ex Taq (Takara, catalog number: RR420A) with primer pairs (Additional file 2: Table S1). PCR amplifications were performed using the QuantStudio 3 Real-Time PCR System (Thermo Fisher Scientific). Gene expression levels were normalized to those of the tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) housekeeping genes. Quantitative data were analyzed based on the 2−ΔΔCT method.

Oxidative respiration analysis

A high-resolution Oxygraph-2 k respirometer (Oroboros) was used in this study. Oxidative respiration was performed as previously described [24, 25]. Briefly, cells were trypsinized, washed with PBS, resuspended at a density of 2 × 104 cells/ml in DMEM supplemented with 10% FBS and transferred to the chamber of the Oxygraph-2 k instrument. Total oxygen consumption was monitored and the following drugs were injected into the medium as follows: oligomycin (3.5 μM), FCCP (4 μM), antimycin A (2 μM), and rotenone (2 μM) (all from Sigma-Aldrich).

Statistical analysis

Data are presented as the mean ± standard error of the mean (SEM). Statistical analysis was performed using GraphPad Prism 8 (GraphPad Software, San Diego, CA, USA) using one-way ANOVA with Bonferroni's test for multiple comparisons or a Student's t-test for comparisons between two groups. All experiments were independently replicated at least three times. Statistical significance was set at P < 0.05.

Results

Polarization and characterization of macrophages

THP-1 monocytes adhered in response to PMA to generate M0 macrophages. M0 macrophages were further polarized into M1 and M2 macrophages upon stimulation with LPS and IFN-γ or IL4 and IL13, respectively (Fig. 1a). The three macrophage subtypes exhibited high expression of CD68, which is a general macrophage marker (Fig. 1b), compared to levels of the internal control gene YWHAZ. The significant upregulation of CD40, IL1B, and CCL2 was observed in M1 macrophages compared to levels in M0 and M2 macrophages (Fig. 1c). In contrast, significantly higher MRC1, CLEC10A, and CD163 expression was observed in M2 macrophages relative to that in M0 and M1 macrophages (Fig. 1d).

Fig. 1
figure 1

Characterization of polarized macrophages. a Bright-field images showing the morphological appearance of M0, M1, and M2 macrophages. b–d RT-qPCR analysis of the specific macrophage markers expression, such as general marker for macrophages CD68 (b), M1 markers CD40, IL1b and CCL2 (c), M2 markers MRC1, CLEC10a, and CD163 (d). e Fluorescence image of M0, M1, and M2 macrophages immunostained for M1-marker CCR7 (green) and M2-marker CD36 (red). Cell nuclei were counterstained with Hoechst 33,342 (blue). f The quantification of relative fluorescence intensity of CCR7and CD36 by ImageJ. mRNA levels are shown relative to those of M0 macrophage except for CD68, which were set at 1. Data are presented as mean ± SD, N = 3 individual preparations. Statistics were done by one-way ANOVA test with Bonferroni correction. *P < 0.05, **P < 0.01, ***P < 0.001

Full size image

Immunofluorescence for macrophage subtype markers was used to further assess the M0, M1, and M2 macrophage populations (Fig. 1e). M0 macrophages showed slight positive staining for the M1 marker CCR7 and M2 marker CD36. M1 macrophages showed positive staining for CCR7 and negative staining for CD36. In contrast, M2 macrophages were positively stained for CD36 and less positively stained for CCR7. Consistently, quantifying the fluorescence intensity from specific macrophage markers showed significant differences among the three macrophage populations (Fig. 1f). The expression of CCR7 was significantly higher in M1 macrophages than in M0 and M2 macrophages. In contrast, CD36 was more highly expressed in M2 macrophages than in M0 or M1 macrophages.

M0, M1, and M2 macrophages suppress the cell viability of iPSCs.

To investigate whether macrophages affect the viability and proliferation of iPSCs, M0, M1, and M2 macrophages were co-cultured with iPSCs using a Transwell system (Fig. 2a). After 3 days of co-culture, all three macrophage subtypes significantly inhibited the proliferative capacity of iPSCs, as shown by the smaller cell cluster sizes and decreased cell numbers in iPSC-M0, iPSC-M1, and iPSC-M2 groups compared with those in the iPSC-Mono group (Fig. 2b, c). Consistently, the viability of iPSCs in iPSC-M0, iPSC-M1, and iPSC-M2 groups was lower than that in the iPSC-Mono group, indicating that M0, M1, and M2 macrophages suppress the viability of iPSCs (Fig. 2d).

Fig. 2
figure 2

Cell proliferation of iPSCs co-cultured with M0, M1, or M2 macrophages. a Scheme showing the set-up of iPSCs proliferation in a monoculture or co-cultured with M0, M1, and M2 macrophages using a transwell system. b Fluorescence image of the cell nuclei of iPSCs monoculture or co-cultured for 3 days with M0, M1, and M2 macrophages stained with Hoechst 33,342 (blue). c Quantification of cell nuclei in iPSCs cultures with indicated conditions. d Cell viability analysis of iPSCs cultures with indicated conditions performed by CCK8. iPSC-Mono, iPSCs monoculture; iPSC-M0, iPSCs co-cultured with M0; iPSC-M1, iPSCs co-cultured with M1; iPSC-M2, iPSCs co-cultured with M2. Data are presented as mean ± SEM, N = 3 individual preparations. Statistics were done by one-way ANOVA test with Bonferroni correction. ***P < 0.001

Full size image

Effects of macrophages on cardiomyogenic differentiation capacity of iPSCs

To evaluate the influence of macrophages on the cardiomyogenic capacity, iPSCs were subjected to cardiomyogenic differentiation in the presence of M0, M1, and M2 macrophages (Fig. 3a). iPSCs were first differentiated into cardiac mesoderm precursors to initiate cardiomyogenic differentiation and subsequently differentiated into CMs with or without exposure to macrophages. After CM purification at the end of the differentiation period, almost all cells were stained positive for the cardiac sarcomeric protein α-actinin in all four culture conditions, that is iPSC-CM-Mono, iPSC-CM-M0, iPSC-CM-M1, and iPSC-CM-M2 groups. iPSC-CM-M0 and iPSC-CM-M2 groups achieved similar CM yields and possessed highly organized sarcomeres, as with that observed in the iPSC-CM-Mono group. However, the cell yield was significantly lower in the iPSC-CM-M1 culture than in the iPSC-CM-Mono culture (Fig. 3b, c). These findings suggest that M1 macrophages inhibit the cardiomyogenic differentiation capacity of iPSCs in terms of the CM yield.

Fig. 3
figure 3

Cardiac differentiation capacity of iPSCs co-cultured with M0, M1, and M2 macrophages. a Scheme showing the set-up of iPSCs cardiomyogenic differentiation in a monoculture or co-cultured with M0, M1, and M2 macrophages using a transwell system. Cardiac mesoderm precursors were first derived from iPSCs. Then the cardiac mesoderm precursors continued cardiomyogenic differentiation in a monoculture or co-cultured with M0, M1, and M2 macrophages using a transwell system. b Fluorescence image of iPSC-CM-Mono, iPSC-CM-M0, iPSC-CM-M1, and iPSC-CM-M2 stained for sarcomeric α-actinin (red). Cell nuclei were counterstained with Hoechst 33,342 (blue). c Quantification of cell nuclei in cultures with indicated conditions by ImageJ. iPSC-CM, iPSCs derived CM; iPSC-CM-Mono, iPSC derived CM in monoculture; iPSC-CM-M0, iPSCs derived CM in a co-culture with M0; iPSC-CM-M1, iPSCs derived CM in a co-culture with M1; iPSC-CM-M2, iPSCs derived CM in a co-culture with M2

Full size image

Effects of macrophages on the myofibrillogenesis of hiPSC-CMs

To determine the effects of macrophages on the myofibrillogenesis of iPSC-CMs, we examined sarcomeres in iPSC-CMs co-cultured with different macrophage subtypes. RT-qPCR analysis of iPSC-CM-Mono culture versus iPSC-CM-M2 culture revealed enhanced CM structural maturation in the latter, with upregulation of the crucial cardiac sarcomeric genes ACTN2, TNNC1, MYH6, MYH7, MYL2, MYL3, MYL4, and MYL7, which are essential for sarcomere assembly and function in the mammalian heart (Fig. 4a). In contrast, iPSC-CM-M1 cultures showed decreased cardiac sarcomeric gene expression compared to that in the iPSC-CM-Mono group. A similar trend in sarcomeric gene expression was observed for iPSC-CM-M0 and iPSC-CM-Mono groups (Fig. 4a).

Fig. 4
figure 4

Structural maturation of iPSC-CMs co-cultured with M0, M1, or M2 macrophages. a RT-qPCR analysis of the cardiac sarcomeric genes expression. b Fluorescence image of cardiac differentiated iPSC cultures co-cultured with M0, M1, or M2 macrophages immunostained for α-actinin (red). Cell nuclei were counterstained with Hoechst 33,342 (blue). mRNA levels are shown relative to those of M0 macrophage, which were set at 1. Data are presented as mean ± SEM, N = 3 individual preparations. Statistics were done by one-way ANOVA test with Bonferroni correction. *P < 0.05

Full size image

Furthermore, immunostaining for α-actinin in iPSC-CMs confirmed improved sarcomere organization in the iPSC-CM-M2 culture compared to that in the iPSC-CM-Mono group (Fig. 4b). In the iPSC-CM-M1 group, α-actinin formed a punctate staining pattern reminiscent of immature myofibrils, consistent with their decreased sarcomeric gene expression (Fig. 4b). These data revealed that M2 macrophages improved, whereas M1 macrophages inhibited, the structural maturation of iPSC-CMs.

Effects of macrophages on ion transport-related gene expression in iPSC-CMs

To determine whether structural maturation was accompanied by electrical maturation, we compared the levels of ion transport-related gene expression in iPSC-CMs co-cultured with different macrophage types. RT-qPCR targeting genes encoding cardiac ion channels (SCN5A/Nav1.5, CACNA1C/Cav1.2, KCNH2/Kv11.1, and KCNJ11/Kir6.2), a gap junction protein (GJA1/Cx43), and cardiac Ca2+-handling proteins (RYR2 and ATP2A2/Serca2) showed an increase in mRNA levels in iPSC-CM-M2 cultures compared to those in iPSC-CM-Mono cultures (Fig. 5a–c). The iPSC-CM-M0 group expressed approximately equal levels of ion transport-related genes relative to those in the iPSC-CM-Mono group (Fig. 5a–c). However, ion transport-related gene expression was significantly decreased in iPSC-CM-M1 cultures (Fig. 5a–c). These findings suggested that M2 macrophages increased, whereas M1 macrophages suppressed, the expression of ion transport-related genes.

Fig. 5
figure 5

Analysis of the cardiac ion transport-related gene expression in hiPSC-CMs co-cultured with different macrophages. The mRNA levels of ion channel genes (a), gap junction protein gene (b), and cardiac Ca2+-handling protein genes (c) were tested by RT-qPCR. The mRNA levels are shown relative to those of the M0 macrophage, which were set at 1. Data are presented as mean ± SEM, N = 3 individual preparations. Statistics were done by one-way ANOVA test with Bonferroni correction. *P < 0.05, **P < 0.01

Full size image

Effects of macrophages on metabolic maturation of iPSC-CMs

To determine whether structural and electrical maturation was accompanied by enhanced metabolism, we first compared metabolic gene signatures among the four cultures using RT-qPCR analysis. RT-qPCR data showed a reduction in glycolysis-associated genes (HK1, PFK, PDH, and GLUT1) and an increase in fatty acid β-oxidation-associated genes (ACADM, ACOX1, CPT1A, and CPT1B) in iPSC-CM-M2 cultures compared to those in iPSC-CM-Mono cultures (Fig. 6a, b). In contrast, iPSC-CM-M1 cultures had a greater preference for glycolysis over mitochondrial respiration, as shown by the higher expression of glycolysis-associated genes and lower expression of fatty acid β-oxidation-associated genes compared to levels in the iPSC-CM-Mono group (Fig. 6a, b).

Fig. 6
figure 6

Metabolic maturation of hiPSC-CMs. a and b RT-qPCR analysis of the glycolysis-associated genes (a) and fatty acid β-oxidation genes expression (b). c Traces and d quantification graph for OCR measured by Seahorse respirometry in hiPSC-CMs co-cultured with M0, M1, or M2 macrophages. The mRNA levels are shown relative to those of the M0 macrophage, which were set at 1. Data are presented as mean ± SEM, N = 3 individual preparations. Statistics were done by one-way ANOVA test with Bonferroni correction. *P < 0.05, **P < 0.01, ***P < 0.001. OCR, oxygen consumption rate

Full size image

Mitochondrial respiration of M1 and M2 macrophages was measured using an Oxygraph-2 k respirometer. The mitochondrial respiration capacity of iPSC-CM-M2 cultures was significantly higher than that of iPSC-CM-M1 cultures (Fig. 6c, d). The enhanced mitochondrial respiratory capacity of the iPSC-CM-M2 group compared to that in the iPSC-CM-M1 group indicated that M2 macrophages enhanced the metabolic maturation of iPSC-CMs compared to that with M1 macrophages.

Discussion

Myocardial infarction remains the leading cause of death worldwide. Many studies have shown that implanted iPSCs can diminish the cardiac scar size and improve functional recovery of the injured myocardium [26, 27]. A better understanding of how the surrounding inflammatory environment influences iPSC survival and cardiac differentiation capability is required to maximize therapeutic efficacy. However, previous studies have generally focused on the effects of macrophages on the existed cardiac fibroblasts and cardiomyocytes [28,29,30], mostly without considering the role of M1/M2 macrophages in the survival and cardiac differentiation of iPSCs. Therefore, in the present study, we differentiated and characterized three macrophage subtypes and assessed their effects on iPSC behavior. All three macrophage subtypes suppressed iPSC proliferation. M2 macrophages promoted the cardiac differentiation ability of co-cultured iPSCs in terms of sarcomeric structures, contractile and electrophysiological gene expression, and mitochondrial respiration. In contrast, M1 macrophages displayed the opposite effects compared to those of M2 macrophages.

Before the co-culture process, we evaluated the influence of the cardiac differentiation medium on the properties of macrophages. As shown in Additional files 1 and 3: Fig. S1a, the expression of CD68, a macrophage marker, was not significantly different between M0 macrophages cultured in a macrophage growth medium and those cultured in a cardiomyogenic differentiation medium. The same was observed for M1 and M2 macrophages regarding the expression of their specific markers (IL1B, CD40, CCL2, MRC1, CLEC10A, and CD163). Consistently, immunostaining for macrophage markers in macrophages cultured with a cardiomyogenic differentiation medium showed the same pattern as that with macrophage growth medium (Additional files 1 and 3: Fig. S1b and Fig. 1e). Taken together, these data indicated that the cardiac differentiation medium had no significant effect on the properties of M0, M1, and M2 macrophages. Therefore, complete cardiac differentiation medium was used to culture macrophages and generate iPSC-CMs over the co-culture period.

The CM yield in the iPSC-CM-M2 group was slightly higher than that in the iPSC-CM-Mono group (Fig. 3b, c). This phenomenon might result from the effects of M2 macrophages on BMP proteins expression in the co-cultured cells. Previous studies have proven that BMP proteins, especially BMP2, are key players in cardiogenesis [31,32,33]. Although the levels of BMP-2 secretion among M0, M1, and M2 macrophages were not significantly different [34], studies have shown that M2 macrophages have the ability to enhance autologous BMP-2 production in co-cultured cells [35, 36]. However, the role of BMP-2 in promoting the cardiac differentiation of iPSCs co-cultured with M2 macrophages requires further investigation.

Immunostaining for α-actinin in the culture after CM purification at the end of the differentiation period revealed that iPSC-CM-M2 cultures possessed highly organized sarcomeres, even better than those in the iPSC-CM-Mono group. In contrast, in the iPSC-CM-M1 group, α-actinin formed a punctate staining pattern, reminiscent of immature myofibrils (Fig. 4b). This is particularly relevant to the high expression levels of genes encoding cardiac sarcomeric and Ca2+-handling proteins in iPSC-CM-M2 cultures and the low expression levels in iPSC-CM-M1 cultures (Fig. 4a). This finding is consistent with a previous study, which indicated that M2 macrophages enhanced, whereas M1 macrophages reduced, the calcium-handling function of CMs [29]. Their study showed that the conditioned medium from M1 macrophages significantly decreased cardiac troponin T (cTnT) and sarcoplasmic/endoplasmic reticulum calcium ATPase (Serca2/Atp2a2) gene expression. It was also demonstrated that the co-culture of M2 macrophages significantly enhanced Ca2+ release in CMs [29, 37]. Several studies have investigated the role of macrophages on CM viability. One examined the effects of proinflammatory macrophages on the survival of rat H9c2 cells. They found that exposure to proinflammatory macrophages led to myocyte apoptosis via mitochondrial damage [38]. Another study reported that the addition of M1 conditioned medium decreased the proliferation ability of CMs compared to that of anti-inflammatory macrophages [39]. In addition, the suppression of macrophage infiltration or proinflammatory cytokine production facilitates cardiac healing and improves cardiac function recovery [40].

Different phenotypic and functional macrophage subtypes are along with dramatic metabolic differences. M1 macrophages exhibit increased glycolysis accompanied by decreased oxygen consumption [41, 42]. M1 macrophages rely on glycolysis to produce ATP, whereas their TCA cycle has two brakes [43, 44], thus reducing oxidative phosphorylation and fatty acid oxidation [43, 45, 46]. In contrast, the metabolic characteristics of M2 macrophages include intensive oxidative phosphorylation and fatty acid oxidation [43]. The TCA cycle of M2 macrophages is intact and meets their ATP requirements by providing substrates for the electron transport chain [43]. Some metabolic products function as mediators of key signaling pathways [47], affecting not only host cells but also adjacent cells. Thus, metabolic products generated from different macrophage subtypes might lead to significant differences in the metabolic signatures of co-cultured iPSC-CMs (Fig. 6).

Interestingly, we found that M2 macrophages enhanced the cardiac differentiation and maturation of iPSCs, whereas both M1 and M2 macrophages inhibited the proliferation of iPSCs. Future studies are required to fully understand the regulatory mechanisms of macrophages with respect to the behavior of iPSCs, specifically regarding mitochondrial function.

Conclusions

In this study, we systematically investigated the influence of different macrophage subtypes on the proliferation, cardiac differentiation, and maturation of human iPSCs. We found that all three types of macrophages significantly reduced iPSC proliferation. Furthermore, we demonstrated that M2 macrophages had a beneficial effect on iPSC cardiomyogenesis by promoting their maturation in terms of the sarcomere structure, electrophysiological-associated gene expression, and mitochondrial functions. This enhanced effect was not observed when the cells were co-cultured with M0 macrophages. M1 macrophages, however, inhibited the cardiac differentiation and maturation of iPSCs. Our findings not only elucidated the critical role of macrophages in the proliferation and cardiomyogenesis of iPSCs but also provided essential guidance for the implantation of iPSCs into the infarcted heart for heart regeneration therapy.

Availability of data and materials

All data are available from the corresponding author on reasonable request.

Abbreviations

iPSC:

Induced pluripotent stem cell

CM:

Cardiomyocyte

iPSC-CM:

Induced pluripotent stem cell derived cardiomyocyte

MI:

Myocardial infarction

PMA:

Phorbol 12-tetradecanoate 13-acetate

LPS:

Lithium phosphorus sulfide

IFN-γ:

Interferon-gamma

IL4:

Interleukin4

IL13:

Interleukin13

YWHAZ:

Tryptophan 5-monooxygenase activation protein zeta

IL1B:

Interleukin 1 beta

CCL2:

C–C motif chemokine ligand 2

MRC1:

Mannose receptor C-type 1

CLEC10A:

C-type lectin domain containing 10A

CCR7:

C–C motif chemokine receptor 7

OD:

Optical density

RT-qPCR:

Reverse transcription-quantitative polymerase chain reaction

GAPDH:

Glyceraldehyde-3-phosphate dehydrogenase

FBS:

Fetal bovine serum

FCCP:

Carbonyl cyanide p-trifluoromethoxyphenylhydrazone

cTnT:

Cardiac troponin T

iPSC-M0:

IPSCs co-culture with M0

iPSC-M1:

IPSCs co-culture with M1

iPSC-M2:

IPSCs co-culture with M2

iPSC-Mono:

IPSCs monoculture

iPSC-CM-Mono:

IPSC derived CM in monoculture

iPSC-CM-M0:

IPSCs derived CM in a co-culture with M0

iPSC-CM-M1:

IPSCs derived CM in a co-culture with M1

iPSC-CM-M2:

IPSCs derived CM in a co-culture with M2

ACTN2:

Actinin alpha 2

TNNC1:

Troponin C1

MYH6:

Myosin heavy chain 6

MYH7:

Myosin heavy chain 7

MYL2:

Myosin light chain 2

MYL3:

Myosin light chain 3

MYL4:

Myosin light chain 4

MYL7:

Myosin light chain 7

SCN5A:

Sodium voltage-gated channel alpha subunit 5

Nav1.5:

Sodium channel protein 1.5

CACNA1C:

Calcium voltage-gated channel subunit alpha1 C

Cav1.2:

Calcium channel protein 1.2

KCNH2:

Potassium voltage-gated channel subfamily H member 2

Kv11.1:

Potassium channel protein 11.1

KCNJ11:

Potassium inwardly rectifying channel subfamily J member 11

Kir6.2:

ATP-sensitive potassium channel subunit 6.2

GJA1:

Gap junction protein alpha 1

Cx43:

Connexin 43

RYR2:

Ryanodine receptor 2

ATP2A2:

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2

Serca2:

Sarcoplasmic/endoplasmic reticulum calcium ATPase 2

HK1:

Hexokinase 1

PFK:

6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3

PDH:

Pyruvate dehydrogenase phosphatase catalytic subunit 1

GLUT1:

Solute carrier family 2 member 1

ACADM:

Acyl-CoA dehydrogenase medium chain

ACOX1:

Acyl-CoA oxidase 1

CPT1A:

Carnitine palmitoyltransferase 1A

CPT1B:

Carnitine palmitoyltransferase 1B

References

  1. Zhou S, Jin P, Wang Q, Zhang G, Freedman J, Zheng Y, et al. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin. 2018;39:1073–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Laslett L, Alagona P, Clark B, Drozda J, Saldivar F, Wilson S, et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol. 2012;60:S1-49.

    Article  PubMed  Google Scholar 

  3. Heusch G, Libby P, Gersh B, Yellon D, Böhm M, Lopaschuk G, et al. Cardiovascular remodelling in coronary artery disease and heart failure. Lancet. 2014;383:1933–43.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ng K, Law C, Tse H. Clinical potentials of cardiomyocytes derived from patient-specific induced pluripotent stem cells. J Clin Med. 2014;3:1105–23.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Bekhite M, Delgado A, Menz F, Tom K, Wu J, Bekfani T, et al. Longitudinal metabolic profiling of cardiomyocytes derived from human-induced pluripotent stem cells. Basic Res Cadiol. 2020;115:37.

    Article  CAS  Google Scholar 

  6. Egashira T, Yuasa S, Tohyama S, Kuroda Y, Suzuki T, Seki T, et al. Patient-specific induced pluripotent stem cell models: characterization of iPS cell-derived cardiomyocytes. Methods Mol Biol. 2016;1353:343–53.

    Article  CAS  PubMed  Google Scholar 

  7. Yeung E, Fukunishi T, Bai Y, Bedja D, Pitaktong I, Mattson G, et al. Cardiac regeneration using human-induced pluripotent stem cell-derived biomaterial-free 3D-bioprinted cardiac patch in vivo. J Tissue Eng Regen Med. 2019;13:2031–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Xuan W, Wang Y, Tang Y, Ali A, Hu H, Maienschein-Cline M, et al. Cardiac progenitors induced from human induced pluripotent stem cells with cardiogenic small molecule effectively regenerate infarcted hearts and attenuate fibrosis. Shock. 2018;50:627–39.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Gao L, Kupfer M, Jung J, Yang L, Zhang P, Da Sie Y, et al. Myocardial tissue engineering with cells derived from human-induced pluripotent stem cells and a native-like, high-resolution, 3-dimensionally printed scaffold. Circ Res. 2017;120:1318–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wendel J, Ye L, Tao R, Zhang J, Zhang J, Kamp T, et al. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model. Stem Cells Transl Med. 2015;4:1324–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Prabhu S, Frangogiannis N. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119:91–112.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, et al. CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res. 2005;96:881–9.

    Article  CAS  PubMed  Google Scholar 

  13. Peet C, Ivetic A, Bromage D, Shah A. Cardiac monocytes and macrophages after myocardial infarction. Cardiovasc Res. 2020;116:1101–12.

    Article  CAS  PubMed  Google Scholar 

  14. Zajac E, Schweighofer B, Kupriyanova T, Juncker-Jensen A, Minder P, Quigley J, et al. Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood. 2013;122:4054–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Troidl C, Möllmann H, Nef H, Masseli F, Voss S, Szardien S, et al. Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction. J Cell Mol Med. 2009;13:3485–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Swirski F, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 2013;339:161–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Honold L, Nahrendorf M. Resident and monocyte-derived macrophages in cardiovascular disease. Circ Res. 2018;122:113–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Nahrendorf M, Swirski F, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo J, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. 2007;204:3037–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Freytes D, Kang J, Marcos-Campos I, Vunjak-Novakovic G. Macrophages modulate the viability and growth of human mesenchymal stem cells. J Cell Biochem. 2013;114:220–9.

    Article  CAS  PubMed  Google Scholar 

  20. Chang Y, Li Y, Bai R, Wu F, Ma S, Saleem A, et al. hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation. Stem Cell Rep Ther. 2021;12:278.

    Article  CAS  Google Scholar 

  21. Jiang S, Zhao H, Zhang W, Wang J, Liu Y, Cao Y, et al. An automated organoid platform with inter-organoid homogeneity and inter-patient heterogeneity. Cell Rep Med. 2020;1: 100161.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Yu Z, Liu J, van Veldhoven J, Ijzerman A, Schalij M, Pijnappels D, et al. Allosteric modulation of Kv11.1 (hERG) channels protects against drug-induced ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2016;9:e003439.

    Article  CAS  PubMed  Google Scholar 

  23. Liu J, Volkers L, Jangsangthong W, Bart C, Engels M, Zhou G, et al. Generation and primary characterization of iAM-1, a versatile new line of conditionally immortalized atrial myocytes with preserved cardiomyogenic differentiation capacity. Cardiovasc Res. 2018;114:1848–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Boukalova S, Stursa J, Werner L, Ezrova Z, Cerny J, Bezawork-Geleta A, et al. Mitochondrial targeting of metformin enhances its activity against pancreatic cancer. Mol Cancer Ther. 2016;15:2875–86.

    Article  CAS  PubMed  Google Scholar 

  25. Rohlenova K, Sachaphibulkij K, Stursa J, Bezawork-Geleta A, Blecha J, Endaya B, et al. Selective disruption of respiratory supercomplexes as a new strategy to suppress Her2(high) breast cancer. Antioxid Redox Signal. 2017;26:84–103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Miller J, Mardhekar N, Pretorius D, Krishnamurthy P, Rajasekaran N, Zhang J, et al. DNA damage-free iPS cells exhibit potential to yield competent cardiomyocytes. Am J Physiol Heart Circ Physiol. 2020;318:H801-h815.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Yanamandala M, Zhu W, Garry D, Kamp T, Hare J, Jun H, et al. Overcoming the roadblocks to cardiac cell therapy using tissue engineering. J Am Coll Cardiol. 2017;70:766–75.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Revelo X, Parthiban P, Chen C, Barrow F. Cardiac resident macrophages prevent fibrosis and stimulate angiogenesis. Circ Res. 2021;129:1086–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hitscherich P, Xie L, Del Re D, Lee E. The effects of macrophages on cardiomyocyte calcium-handling function using in vitro culture models. Physiol Rep. 2019;7: e14137.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Ong S, Hernandez-Resendiz S, Crespo-Avilan G, Mukhametshina R, Kwek X, Cabrera-Fuentes H, et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018;186:73–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Ghosh-Choudhury N, Abboud S, Chandrasekar B, Choudhury G. BMP-2 regulates cardiomyocyte contractility in a phosphatidylinositol 3 kinase-dependent manner. FEBS Lett. 2003;544:181–4.

    Article  CAS  PubMed  Google Scholar 

  32. Pater E, Ciampricotti M, Priller F, Veerkamp J, Strate I, Smith K, et al. Bmp signaling exerts opposite effects on cardiac differentiation. Circ Res. 2012;110:578–87.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Ebelt H, Hillebrand I, Arlt S, Zhang Y, Kostin S, Neuhaus H, et al. Treatment with bone morphogenetic protein 2 limits infarct size after myocardial infarction in mice. Shock. 2013;39:353–60.

    Article  CAS  PubMed  Google Scholar 

  34. Zhang Y, Bose T, Unger R, Jansen J, Kirkpatrick C, van den Beucken J. Macrophage type modulates osteogenic differentiation of adipose tissue MSCs. Cell Tissue Res. 2017;369:273–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Ekstrom K, Omar O, Graneli C, Wang X, Vazirisani F, Thomsen P. Monocyte exosomes stimulate the osteogenic gene expression of mesenchymal stem cells. PLoS ONE. 2013;8: e75227.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Omar O, Graneli C, Ekstrom K, Karlsson C, Johansson A, Lausmaa J, et al. The stimulation of an osteogenic response by classical monocyte activation. Biomaterials. 2011;32:8190–204.

    Article  CAS  PubMed  Google Scholar 

  37. Revuelta-López E, Cal R, Herraiz-Martínez A, de Gonzalo-Calvo D, Nasarre L, Roura S, et al. Hypoxia-driven sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) downregulation depends on low-density lipoprotein receptor-related protein 1 (LRP1)-signalling in cardiomyocytes. J Mol Cell Cardiol. 2015;85:25–36.

    Article  PubMed  CAS  Google Scholar 

  38. Ai X, Lu W, Zeng K, Li C, Jiang Y, Tu P. Microfluidic coculture device for monitoring of inflammation-induced myocardial injury dynamics. Anal Chem. 2018;90:4485–94.

    Article  CAS  PubMed  Google Scholar 

  39. Pallotta I, Sun B, Wrona E, Freytes D. BMP protein-mediated crosstalk between inflammatory cells and human pluripotent stem cell-derived cardiomyocytes. J Tissue Eng Regen Med. 2017;11:1466–78.

    Article  CAS  PubMed  Google Scholar 

  40. Ji N, Lou H. Treatment with 3-Bromo-4,5-dihydroxybenzaldehyde Improves Cardiac Function by Inhibiting Macrophage Infiltration in Mice. Korean Circ J. 2018;48:933–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Hard G. Some biochemical aspects of the immune macrophage. Br J Exp Pathol. 1970;51:97–105.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Freemerman A, Johnson A, Sacks G, Milner J, Kirk E, Troester M, et al. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J Biol Chem. 2014;289:7884–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Jha A, Huang S, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015;42:419–30.

    Article  CAS  PubMed  Google Scholar 

  44. Meiser J, Kramer L, Sapcariu S, Battello N, Ghelfi J, D’Herouel A, et al. Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J Biol Chem. 2016;291:3932–46.

    Article  CAS  PubMed  Google Scholar 

  45. Funk J, Feingold K, Moser A, Grunfeld C. Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis. 1993;98:67–82.

    Article  CAS  PubMed  Google Scholar 

  46. Feingold K, Shigenaga J, Kazemi M, McDonald C, Patzek S, Cross A, et al. Mechanisms of triglyceride accumulation in activated macrophages. J Leukoc Biol. 2012;92:829–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Singer K, Cheng W, Kreutz M, Ho P, Siska P. Immunometabolism in cancer at a glance. Dis Model Mech. 2018;11:dmm034272.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr. Yang Zhang and Dr. Chengbin Yang from Shenzhen University for their suggestions and for providing some of the reagents. We would like to thank Editage (www.editage.cn) for English language editing. We also thank Mrs. Lei Zhang for her assistance.

Funding

This work was granted by the National Natural Science Foundation of China (81900264), the Shenzhen Science and Technology Innovation Commission (JCYJ20210324130609027 and JCYJ20190814121601671), the Project of Administration of Traditional Chinese Medicine Guangdong Province (20211347), the Longgang Medical and Health Science and Technology Project (LGKCYLWS2020040, LGKCYLWS2019000393, LGKCYLWS2020043, LGKCYLWS2020044, and LGKCYLWS2020045).

Author information

Authors and Affiliations

  1. Central Laboratory, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People’s Hospital of Shenzhen, Shenzhen, 518172, Guangdong, China

    Canling Long, Rui Guo, Kang Li, Yanbing Wan, Xiaoyu Gong, Yanqiu Zhao, Xinhuang Yao & Jia Liu

  2. Department of Cardiology, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People’s Hospital of Shenzhen, Shenzhen, 518172, Guangdong, China

    Ruijuan Han

  3. Cardiothoracic Surgery Department, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People’s Hospital of Shenzhen, Shenzhen, 518172, Guangdong, China

    Jiqing Xu

Authors
  1. Canling Long
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rui Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ruijuan Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yanbing Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jiqing Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiaoyu Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yanqiu Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xinhuang Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jia Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JL and CL designed the experiments; CL, RG and XY performed the experiments; CL, JX and XG analyzed the data; RH, KL and YW contributed to data interpretation and manuscript revising; JL wrote the paper. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jia Liu.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Supplemental Figure Legends.

Additional file 2.

Supplemental Table.

Additional file 3.

Supplemental Figure.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Long, C., Guo, R., Han, R. et al. Effects of macrophages on the proliferation and cardiac differentiation of human induced pluripotent stem cells. Cell Commun Signal 20, 108 (2022). https://doi.org/10.1186/s12964-022-00916-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12964-022-00916-1

Keywords

Cell Communication and Signaling

ISSN: 1478-811X